ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 27445 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 27445; 2) Community: the network communities that were significantly associated with the response to NSC 27445; 3) Molecule: the relationships between components within communities and NSC 27445; 4) MDR: the compounds that were significantly associated with the NSC 27445.

NSC Compound Enrichment Correlation
NSC 726365 Null 0.022188614181866 0.31188161
NSC 727086 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate 0.022188614181866 0.16116649
NSC 748643 Mitaplatin 0.022188614181866 0.17111698
NSC 749226 Abiraterone 0.022188614181866 0.13870384
NSC 752503 2,7-Bis-[2-(3,4,5-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone dipara-toluensulfonate dihydrate salt 0.022188614181866 -0.015579458
NSC 29638 Null 0.0237269271456697 0.12314707
NSC 329515 Kijanimicin sodium salt 0.0237269271456697 0.22036635
NSC 35676 PURPUROGALLIN 0.0237269271456697 0.33112198
NSC 405159 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, 4-oxo-.alpha.-phenyl-, oxime 0.0237269271456697 0.19032379
NSC 56410 Porfiromycin 0.0237269271456697 0.2293157
Total:43  Current:22    [First] [Prev] [Next] [Last]